Skip to content
Patient Evaluation Tracker MTD: 47,546 YTD: 1,075,065

Articles

Trusted retinal and eye care articles for patients and healthcare providers.

90 articles

List last updated Nov 16, 2026 · new articles added weekly

Article
Andelyn partners with Celliaz to advance gene therapy for retinitis pigmentosa (opens in a new tab)

Andelyn Biosciences (Andelyn), a leading US-based patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), and Celliaz Co., Ltd., a South Korean biotechnology company developing next-generation regenerative therapeutics for retinal degener...

Retinal Conditions · news-medical.net

Concerns rise over copay assistance program funding in retina (opens in a new tab)

NEW YORK — To address gaps in access to retinal therapies, ophthalmologists must encourage companies to support underfunded copay assistance programs, while industry must work with policymakers to improve options for patients. According to a presentation at OSN New York Retina, a...

Treatment & Prevention · healio.com

Low dose of NG101 gene therapy produces ‘potent biological effect’ in wet AMD (opens in a new tab)

NEW ORLEANS — In this video, Robert A. Sisk, MD, FACS, FASRS, of Cincinnati Eye Institute, highlights a trial that assessed the use of an adeno-associated viral vector gene therapy for the treatment of wet age-related macular degeneration. In a phase 1/2a dose escalation trial pr...

Retinal Conditions · healio.com

New test identifies people at higher risk of glaucoma, the leading cause of irreversible blindness (opens in a new tab)

A new genetic test developed by researchers at QIMR Berghofer and Flinders University, along with international collaborators, can identify people at up to 10 times the normal risk of developing open-angle glaucoma, the most common form of the disease and the leading cause of irr...

Retinal Conditions · medicalxpress.com

Imvionix acquires commercial rights to Beovu in US, Canada (opens in a new tab)

Editor’s note: This is a developing story. Please check back soon for updates. Imvionix has acquired the commercial rights to Beovu in the United States and Canada, according to a press release. The company acquired Beovu (brolucizumab-dbll) from Novartis. Financial terms of the...

Diabetic Retinopathy · healio.com

IOLs may experience adverse effects in space (opens in a new tab)

One day in the not-so-distant future, someone is going to need cataract surgery in space, J. Morgan Micheletti, MD, FACS, said at the European Society of Cataract and Refractive Surgeons meeting. To do that, Micheletti said, researchers will to need to figure out how to ship IOLs...

Treatment & Prevention · healio.com

AI-powered bionic eye breakthrough could help the blind see again (opens in a new tab)

Scientists have developed an AI-powered approach that makes experimental bionic vision technology more precise, helping predict the flashes and shapes of light perceived by a blind man with a brain implant. By learning how an individual's brain responds to electrical stimulation,...

Screening & Detection · sciencedaily.com

Fixate a new lens in eye with ‘dead bag syndrome’ (opens in a new tab)

NEW YORK — Surgeons should have a plan to fixate a new IOL in patients with “dead bag syndrome,” according to a speaker at OSN New York. Nicole R. Fram, MD, told Healio that the term “dead bag syndrome” was coined by Samuel Masket, MD, after he noticed patients with capsular bags...

Eye Care News · healio.com

Luminopia improves stereoacuity in real-world pediatric cohort (opens in a new tab)

NEW ORLEANS — Luminopia, a virtual reality-based dichoptic therapy, produced improvements in stereoacuity and best corrected visual acuity in pediatric patients with amblyopia, according to a speaker. At the American Academy of Ophthalmology meeting, Brenda L. Bohnsack, MD, PhD,...

Treatment & Prevention · healio.com

Ophthalmology community mourns loss of Kevin Waltz, OD, MD (opens in a new tab)

Kevin Waltz, OD, MD, an ophthalmologist and cofounder of EyeDura Therapeutics, died on Nov. 9. “Dr. Waltz was an accomplished ophthalmic surgeon, researcher, educator and humanitarian whose contributions to ophthalmology and clinical research extended across the United States and...

Treatment & Prevention · healio.com

‘Convincing’ phase 3 data needed for wet AMD gene therapy (opens in a new tab)

NEW ORLEANS — In this video from the American Academy of Ophthalmology meeting, Sharon Fekrat, MD, FACS, FASRS, highlights “exciting” gene therapy programs with phase 3 trials now underway. Fekrat, of Duke Health, detailed encouraging data on 4D-150 (4D Molecular Therapeutics), a...

Retinal Conditions · healio.com

Mogrify to present preclinical proof-of-concept data for first-in-class retinal in vivo reprogramming therapy (opens in a new tab)

Mogrify Limited (Mogrify®), a regenerative medicine company developing a novel class of in vivo reprogramming therapies, today announced it will present preclinical proof-of-concept data at FLORetina-ICOOR 2026.

Treatment & Prevention · news-medical.net

AI agents can improve patient relationships, efficiency in clinic (opens in a new tab)

NEW YORK — When implemented correctly, AI voice agents can not only help cataract surgeons use time more efficiently in the clinic but improve the patient-physician relationship, according to a speaker at OSN New York and Retina. During a presentation, P. Dee G. Stephenson, MD, F...

Screening & Detection · healio.com

Rare eye condition prompts new FDA warning on popular GLP-1 drugs (opens in a new tab)

The U.S. Food and Drug Administration (FDA) is requiring makers of Ozempic, Wegovy and similar drugs to warn of a rare eye condition that can cause vision loss.

Treatment & Prevention · medicalxpress.com

FDA to require NAION risk warning for GLP-1 therapies (opens in a new tab)

The FDA is requiring manufacturers of GLP-1 receptor agonist therapies to include warnings regarding the risk for nonarteritic anterior ischemic optic neuropathy, according to a drug safety communication. The agency conducted a review following the publication of a study by Jimen...

Treatment & Prevention · healio.com

'Mini lens' grown in lab could help tackle cataracts (opens in a new tab)

Scientists have found a way to grow a realistic human lens, potentially providing a new path for the treatment of cataracts, one of the leading causes of blindness worldwide. Researchers from Anglia Ruskin University (ARU), working with colleagues at the University of Osaka in Ja...

Treatment & Prevention · medicalxpress.com

Recurrent visual field progression happens for 1 in 4 with glaucoma, study finds (opens in a new tab)

Recurrent visual field progression after a first guided progression analysis (GPA) progression event is common, according to a study published online Oct. 22 in JAMA Ophthalmology.

Retinal Conditions · medicalxpress.com

Ultrathin optical coherence tomography endoscope could enable imaging during retinal surgery (opens in a new tab)

A team of physicists from the Applied Optics Group at the University of Kent has developed a new design for an ultrathin, forward-viewing endoscope. Together with partners from King's College London and Moorfields Eye Hospital, they have engineered a device that captures optical...

Screening & Detection · medicalxpress.com

New clues about why the eye's iris sheds in pigmentary glaucoma (opens in a new tab)

Yale School of Medicine researchers have discovered new genetic risk factors associated with a subtype of the eye condition glaucoma. The findings highlight a novel mechanism that may contribute to the onset of the disease.

Retinal Conditions · medicalxpress.com

Surgeons take major step toward artificial vision (opens in a new tab)

A third surgery performed at Rush University Medical Center has marked a new chapter in advancing vision restoration for people with total blindness.

Treatment & Prevention · medicalxpress.com

Treatment with norrin helps maintain healthy blood vessels and preserve vision in diabetic rats (opens in a new tab)

Millions of people in the U.S. are affected by diabetic retinopathy, a complication of diabetes that affects the eyes. The condition is caused by damage to the blood vessels in the retina, the light-sensitive tissue at the back of the eye. At first, diabetic retinopathy might not...

Diabetic Retinopathy · medicalxpress.com

A surprising vitamin A discovery is changing what scientists know about vision (opens in a new tab)

Scientists at Johns Hopkins University have uncovered a surprising process that helps humans develop sharp vision before birth, challenging decades of assumptions about how the eye forms. Using miniature human retinas grown in the lab, researchers discovered that a vitamin A deri...

Eye Care News · sciencedaily.com

Norrin treatment prevents vision loss in diabetic rats (opens in a new tab)

Over 100 million people in the U.S. are affected by diabetic retinopathy, a complication of diabetes that affects the eyes.

Diabetic Retinopathy · news-medical.net

Patients with psoriasis have increased risks for cataracts, cataract surgery (opens in a new tab)

Patients with psoriasis have an increased risk for cataracts and cataract surgery, with the risks for these outcomes varying by treatment modality, according to a study published online Oct. 26 in the Journal of Dermatology.

Treatment & Prevention · medicalxpress.com

Tiny corneal bumps reveal potential path toward treating severe vision loss (opens in a new tab)

University of Waterloo researchers have discovered how tiny bumps inside the eye contribute to Fuchs endothelial corneal dystrophy (FECD), an eye disease that can cause severe vision loss. With donated corneas in short supply worldwide, the finding could lead to alternative treat...

Treatment & Prevention · medicalxpress.com

Articles link to the National Eye Institute, American Academy of Ophthalmology, CDC, CMS, American Diabetes Association and other publishers. They are for general education and are not medical advice; Orvos Healthcare is not responsible for content on other sites.